Bausch Health
BHC
#4726
Rank
โ‚น186.00 B
Marketcap
โ‚น501.02
Share price
0.65%
Change (1 day)
11.37%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น90.25. In 2024 the company made an earnings per share (EPS) of -โ‚น11.16 an increase over its 2023 EPS that were of -โ‚น150.72.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-858.64%
2024-โ‚น11.16-92.59%
2023-โ‚น150.72160.89%
2022-โ‚น57.77-76.64%
2021-โ‚น247.3068.45%
2020-โ‚น146.81-68.91%
2019-โ‚น472.17-57.11%
2018-โ‚น1,101-272.22%
2017โ‚น639.29-199.29%
2016-โ‚น643.84798.7%
2015-โ‚น71.64-128.31%
2014โ‚น253.07-204.62%
2013-โ‚น241.90602.7%
2012-โ‚น34.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.33-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.39-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA